Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.4% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Technology | 6.04% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
776
DELISTED
Blueprint Medicines
BPMC
| $20.2K | 0.02% |
217,650
+151,788
| +230% | +$11.7M |
|
|
AONE.U
777
DELISTED
one Units, each consisting of one Class A ordinary share, and one-fourth of a Warrant to acquire one
AONE.U
| $20.2K | 0.02% |
+1,850,565
| New | +$19.3M |
|
|
GOAC.U
778
DELISTED
GO Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of on
GOAC.U
| $20.2K | 0.02% |
+2,000,000
| New | +$20M |
|
779
PUT
Newmont
NEM
$119B
| $20.1K | 0.02% |
1,217,000
+313,400
| +35% | +$20.4M |
|
780
Viatris
VTRS
$18.9B
| $20.1K | 0.02% |
1,355,497
+451,880
| +50% | +$7.21M |
|
781
Idexx Laboratories
IDXX
$46.2B
| $20K | 0.02% |
50,844
+48,115
| +1,763% | +$17.8M |
|
782
Duke Energy
DUK
$97.3B
| $19.8K | 0.02% |
224,127
-45,344
| -17% | -$3.74M |
|
783
Edison International
EIX
$26.4B
| $19.8K | 0.02% |
390,203
-210,757
| -35% | -$11.2M |
|
784
Darling Ingredients
DAR
$9.44B
| $19.7K | 0.02% |
546,541
-259,475
| -32% | -$7.94M |
|
785
Azenta
AZTA
$1.48B
| $19.7K | 0.02% |
424,859
+358,864
| +544% | +$17.4M |
|
786
Service Corp International
SCI
$11.6B
| $19.6K | 0.02% |
465,634
+312,627
| +204% | +$13.3M |
|
787
Elanco Animal Health
ELAN
$11.1B
| $19.6K | 0.02% |
702,780
+1,021
| +0.1% | +$25.9K |
|
|
SNPR.U
788
DELISTED
Tortoise Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of
SNPR.U
| $19.6K | 0.02% |
+1,800,000
| New | +$19.5M |
|
|
SRTA
789
Strata Critical Medical Inc
SRTA
$512M
| $19.6K | 0.02% |
1,946,683
+846,685
| +77% | +$8.55M |
|
790
Vipshop
VIPS
$7.53B
| $19.5K | 0.02% |
1,247,267
+982,311
| +371% | +$19.2M |
|
791
CALL
Micron Technology
MU
$991B
| $19.4K | 0.02% |
414,100
-208,200
| -33% | -$10.1M |
|
792
PUT
Philip Morris
PM
$295B
| $19.3K | 0.02% |
257,200
+10,500
| +4% | +$810K |
|
793
The Mosaic Company
MOS
$7.33B
| $19.3K | 0.02% |
1,054,036
+933,870
| +777% | +$15.2M |
|
794
PUT
NXP Semiconductors
NXPI
$60.4B
| $19.2K | 0.02% |
154,000
+68,400
| +80% | +$8.35M |
|
795
InMode
INMD
$880M
| $19.2K | 0.02% |
1,060,968
+1,006,268
| +1,840% | +$16.5M |
|
796
CALL
JD.com
JD
$44.5B
| $19.1K | 0.02% |
246,700
| – | – |
|
797
Pinduoduo
PDD
$131B
| $19.1K | 0.02% |
258,053
+6,240
| +2% | +$535K |
|
|
ACH
798
Accendra Health
ACH
$214M
| $19.1K | 0.02% |
+760,993
| New | +$11.1M |
|
799
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $19.1K | 0.02% |
11,971
+6,868
| +135% | +$12.2M |
|
800
Philips
PHG
$26.1B
| $19K | 0.02% |
497,936
-135,797
| -21% | -$5.45M |
|
Similar funds
Millennium Management's Q3 2020 Portfolio in Review
As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Millennium Management opened 989 new positions and closed 724 in Q3 2020.
- Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.